Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis

BackgroundThe clinical benefits of postoperative chemotherapy for non-small cell lung cancer (NSCLC) have plateaued, thus highlighting the need for novel strategies. This meta-analysis evaluated the efficacy and safety of adjuvant immunotherapy in patients with completely resected NSCLC and wild-typ...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Hong Huang, Pengchen Bao, Hongyu Jin, Wenyang Li, Hui Shen, Zhen Qin, Ying Pan, Xinming Su, Delei Kong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Subjects:	adjuvant immunotherapy immune checkpoint inhibitors ICIs non-small cell lung cancer NSCLC
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1493221/full